Nathan Diers Promoted Vice President of EyeKor Product Development

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Effective immediately, EyeKor Inc. announced they are promoting Nathan Diers to the role of Vice President of Product Development, leading the development efforts for EXCELSIORTM, EyeKor’s cloud-based, FDA 510(k) cleared, clinical trial image management and analysis software.

Nathan Diers brings 15+ years of research experience in the field of clinical trial management and has been serving as a vital part of EyeKor’s evolution and success since its inception. Over the past five years, Diers has served EyeKor as the Senior Director of Operations. In his new role, Diers will expand his work with study sponsors and central reading centers to develop trial-specific imaging protocols and grading schemes, lead the software development and validation team, and improve the EXCELSIOR™ platform functionality to meet the expanding user needs beyond the field of ophthalmology.

Yijun Huang, CEO of EyeKor, is thrilled with this new promotion. Huang said, “Nathan has been an integral part of EyeKor’s growth. His ability to service EyeKor’s clients and guide the development of our EXCELSIOR™ software makes him an ideal candidate for this position.  We are very excited to welcome Nathan to the executive team.”

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.